Conclusions
Pediatric oncology patients have suboptimal response to COVID-19 vaccination compared to healthy controls. Booster shots should be encouraged to improve immunity and reduce risk of severe disease. Further work in larger cohorts of patients is needed to understand how malignancy type, blood counts, and intensity of therapy may impact immune response.
Conflict of Interest Statement : The authors have no conflicts of interest to discolose.
Acknowledgements : none